NCT07146100View on ClinicalTrials.gov

Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection

Not yet recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

August 21, 2025

Primary Completion Date

January 1, 2028

Study Completion Date

January 1, 2030

Conditions

Chronic Hepatitis B

Trial Locations (2)

Unknown

AusperBio Investigational Site, Guangzhou

AusperBio Investigational Site, Changchun

All Listed Sponsors

lead

Ausper Biopharma Co., Ltd.

INDUSTRY